E. Solak Et Al. , "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study," ERCIYES MEDICAL JOURNAL , no.3, pp.267-272, 2021
Solak, E. Et Al. 2021. Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study. ERCIYES MEDICAL JOURNAL , no.3 , 267-272.
Solak, E., Gokcek, G. E., ÇİNAR, S. L., KARTAL, D., & BORLU, M., (2021). Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study. ERCIYES MEDICAL JOURNAL , no.3, 267-272.
Solak, EDA Et Al. "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study," ERCIYES MEDICAL JOURNAL , no.3, 267-272, 2021
Solak, EDA Ö. Et Al. "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study." ERCIYES MEDICAL JOURNAL , no.3, pp.267-272, 2021
Solak, E. Et Al. (2021) . "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study." ERCIYES MEDICAL JOURNAL , no.3, pp.267-272.
@article{article, author={EDA ÖKSÜM SOLAK Et Al. }, title={Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study}, journal={ERCIYES MEDICAL JOURNAL}, year=2021, pages={267-272} }